Rosuvastatin in Preventing Myonecrosis in Elective Percutaneous Coronary Interventions (PCIs)

NCT01007279 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Periprocedural Myocardial Necrosis

Interventions

DRUG: ROSUVASTATIN

Sponsor

University of Roma La Sapienza